About

Neetu Singh obtained her Bachelors and Masters degrees from the University of Mumbai, after which she moved to USA to perform doctoral work in chemistry with Prof. Andrew Lyon at Georgia Institute of Technology, Atlanta. At Georgia Tech, she worked on developing novel synthetic routes towards the design of multifunctional hydrogel nanoparticles. Following her PhD, she moved to Cambridge, MA to pursue her postdoctoral studies at the Harvard-MIT Division of Health Sciences and Technology with Prof. Sangeeta Bhatia. In the Bhatia laboratory, her research efforts were focused on developing nanomaterials for achieving and investigating RNA therapy. She returned to India and joined as faculty in the Polymer Sciences and Engineering Division at the National Chemical Laboratory (NCL), Pune in 2012. She joined as an Assistant Professor in the Center for Biomedical Engineering (CBME), IIT-Delhi in April 2014 and got promoted to Associate Professor in March 2019. In her current program at IITD, she is establishing a research program that explores systematic probing into nanomaterials biological activity and formulates “design rules” for developing biosystem for specific bio-medical & technological applications.

Her important scientific contribution in developing strategies for managing cancer got her the Kiran Shaw-Mazumdar International Oncology Fellowship, for establishing cancer-based-research ties with MIT, USA. She is also a recipient of the Innovative Young Biotechnologist award 2013, NASI-Scopus Young Scientist Award 2019, and Janaki Ammal-National Women Bioscientist Award 2020-21.

Areas of Interest:

• Structure-activity relationships in design of biologically relevant nanostructures
• Smart Functional Nanomaterials (drug delivery, biosensors and biomedical implant coatings)
• Tissue engineering

Our group is interested in integrating concepts and skills from chemistry, materials science, and biology to design nano-structured materials with enhanced functionality for applications in biomedical implants, cancer diagnostics, and drug delivery. We are particularly focused on seeking a systematic understanding of the bio-activity of nanostructures and developing specific structure-bioactivity relationships. We believe that such a rational approach is necessary for systematically advancing nano-materials and biomedical technologies of the future.